Cargando…
Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways
In this study, we identified a novel pyrazole-based derivative (P3C) that displayed potent cytotoxicity against 27 human cancer cell lines derived from different tissue origins with 50% cytotoxic concentrations (CC(50)) in the low micromolar and nanomolar range, particularly in two triple-negative b...
Autores principales: | Gutierrez, Denisse A., Contreras, Lisett, Villanueva, Paulina J., Borrego, Edgar A., Morán-Santibañez, Karla, Hess, Jessica D., DeJesus, Rebecca, Larragoity, Manuel, Betancourt, Ana P., Mohl, Jonathon E., Robles-Escajeda, Elisa, Begum, Khodeza, Roy, Sourav, Kirken, Robert A., Varela-Ramirez, Armando, Aguilera, Renato J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773755/ https://www.ncbi.nlm.nih.gov/pubmed/35053370 http://dx.doi.org/10.3390/cells11020254 |
Ejemplares similares
-
Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro
por: Hess, Jessica D., et al.
Publicado: (2022) -
Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex
por: Robles-Escajeda, Elisa, et al.
Publicado: (2023) -
Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis
por: Villanueva, Paulina J., et al.
Publicado: (2018) -
The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border
por: Grant, Alice Hernandez, et al.
Publicado: (2021) -
The SARS‐CoV‐2 origin dilemma: Zoonotic transfer or laboratory leak?
por: Ruiz‐Medina, Blanca E., et al.
Publicado: (2021)